SCHOFIELD, Wis., June 2, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M conducted by leading headache researcher Dr. Roger Cady has been published in the “Early View” section of the online edition of Headache, a top-tier medical journal of the American Headache Society, and is expected to be published in the print edition in the near future.
